Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study
NCT ID: NCT07151235
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2025-09-18
2025-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will:
* Have 2 study visits - one visit with exposure to clean air and one visit with exposure to simulated wildfire smoke
* Have blood drawn before and after each exposure
* Complete cognitive tests and memory tasks before and after each exposure
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cleaner Air for Better Cardiac Biomarkers
NCT05379400
Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes
NCT02411240
Effect of Air Pollution on the Cognitive Function of Adolescents
NCT03762239
Air Pollution Study: The Effect of Ozone on the Lung
NCT02673775
Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors
NCT04103346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Simulated wildfire smoke will be generated by burning pine wood at a temperature that mimics smoldering combustion. The levels of smoke introduced into the exposure chamber are similar to those found during outdoor bonfires and wildfire events. The levels of particulate matter (PM) will be closely monitored during the exposure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure to simulated wildfire smoke, then exposure to clean air
At the first study visit the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 Particulate Matter). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM).
Simulated wildfire smoke exposure
1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)
Clean Air exposure
1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)
Exposure to clean air, then exposure to simulated wildfire smoke
At the first study visit the subject undergoes a 1-hour chamber exposure to clean air (0 ug/m3 PM). After a 1-week washout period, the subject undergoes a 1-hour chamber exposure to simulated wildfire smoke (300 ug/m3 PM).
Simulated wildfire smoke exposure
1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)
Clean Air exposure
1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Simulated wildfire smoke exposure
1 hour exposure to simulated wildfire smoke (300 ug/m3 PM)
Clean Air exposure
1 hour exposure to clean (HEPA-filtered) air (0 ug/m3 PM)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non smoker
* Weight at least 110 pounds
* Between ages 18 and 40 years old
Exclusion Criteria
* Colorblindness.
* Inability to hear verbal instructions.
* Cardiovascular disease which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure. This includes a history of stroke.
* Diabetes requiring the use of insulin.
* Pregnancy (A pregnancy test will be provided to you).
* Current asthma (an asthma attack within the past five years).
* History of childhood asthma.
* Medications which may affect cognition such as beta-blockers and CNS depressants.
* Respiratory symptoms in the previous 4 weeks (cough, wheezing, shortness of breath, etc.) which, in the opinion of the investigator, would elevate the participant's risk of adverse effects to WRAP exposure.
* Use of sedating cold/allergy medications in the previous week.
* Use of marijuana in the previous week.
* Consumption of alcohol in the previous 24 hours.
* Kidney or liver disease.
* Thyroid disease.
* High blood pressure.
* Cancer.
* Parkinson's disease.
* Pacemaker.
* Hay fever.
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Guillermo CEDENO LAURENT, ScD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose G Cedeno-Laurent, ScD
Role: PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey: New Brunswick/Piscataway Campus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers-EOHSI
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2025001070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.